A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse

2006/05/27 by Joseph O. Moore, Joseph Moore, Karen Seiter +9 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Acute Myeloid Leukemia Research #Cancer therapeutics and mechanisms #Retinoids in leukemia and cellular processes

paper · doi:10.1016/j.leukres.2005.10.025

openalex publication_date 2006/05/27 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/26

Cited by

• Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress